These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 22253088)
41. Orexin A affects HepG2 human hepatocellular carcinoma cells glucose metabolism via HIF-1α-dependent and -independent mechanism. Wan X; Liu Y; Zhao Y; Sun X; Fan D; Guo L PLoS One; 2017; 12(9):e0184213. PubMed ID: 28886081 [TBL] [Abstract][Full Text] [Related]
42. Perifosine as a potential novel anti-cancer agent inhibits EGFR/MET-AKT axis in malignant pleural mesothelioma. Pinton G; Manente AG; Angeli G; Mutti L; Moro L PLoS One; 2012; 7(5):e36856. PubMed ID: 22590625 [TBL] [Abstract][Full Text] [Related]
43. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells. Li JP; Yang YX; Liu QL; Pan ST; He ZX; Zhang X; Yang T; Chen XW; Wang D; Qiu JX; Zhou SF Drug Des Devel Ther; 2015; 9():1627-52. PubMed ID: 25834401 [TBL] [Abstract][Full Text] [Related]
44. (-)-Liriopein B Suppresses Breast Cancer Progression via Inhibition of Multiple Kinases. Wang HC; Chang FR; Huang TJ; Kuo CY; Tsai YC; Wu CC Chem Res Toxicol; 2015 May; 28(5):897-906. PubMed ID: 25856345 [TBL] [Abstract][Full Text] [Related]
45. Phosphoinositide 3-kinase targeting by the beta galactoside binding protein cytokine negates akt gene expression and leads aggressive breast cancer cells to apoptotic death. Wells V; Mallucci L Breast Cancer Res; 2009; 11(1):R2. PubMed ID: 19133120 [TBL] [Abstract][Full Text] [Related]
46. A phase I/Ib trial targeting the Pi3k/Akt pathway using perifosine: Long-term progression-free survival of patients with resistant neuroblastoma. Kushner BH; Cheung NV; Modak S; Becher OJ; Basu EM; Roberts SS; Kramer K; Dunkel IJ Int J Cancer; 2017 Jan; 140(2):480-484. PubMed ID: 27649927 [TBL] [Abstract][Full Text] [Related]
47. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway. Blancher C; Moore JW; Robertson N; Harris AL Cancer Res; 2001 Oct; 61(19):7349-55. PubMed ID: 11585776 [TBL] [Abstract][Full Text] [Related]
48. Synergistic proapoptotic activity of recombinant TRAIL plus the Akt inhibitor Perifosine in acute myelogenous leukemia cells. Tazzari PL; Tabellini G; Ricci F; Papa V; Bortul R; Chiarini F; Evangelisti C; Martinelli G; Bontadini A; Cocco L; McCubrey JA; Martelli AM Cancer Res; 2008 Nov; 68(22):9394-403. PubMed ID: 19010914 [TBL] [Abstract][Full Text] [Related]
50. Lactate and choline metabolites detected in vitro by nuclear magnetic resonance spectroscopy are potential metabolic biomarkers for PI3K inhibition in pediatric glioblastoma. Al-Saffar NM; Marshall LV; Jackson LE; Balarajah G; Eykyn TR; Agliano A; Clarke PA; Jones C; Workman P; Pearson AD; Leach MO PLoS One; 2014; 9(8):e103835. PubMed ID: 25084455 [TBL] [Abstract][Full Text] [Related]
51. Akt down-modulation induces apoptosis of human prostate cancer cells and synergizes with EGFR tyrosine kinase inhibitors. Festuccia C; Gravina GL; Muzi P; Millimaggi D; Dolo V; Vicentini C; Bologna M Prostate; 2008 Jun; 68(9):965-74. PubMed ID: 18361408 [TBL] [Abstract][Full Text] [Related]
52. Discovery of 1-(3-aryl-4-chlorophenyl)-3-(p-aryl)urea derivatives against breast cancer by inhibiting PI3K/Akt/mTOR and Hedgehog signalings. Li W; Sun Q; Song L; Gao C; Liu F; Chen Y; Jiang Y Eur J Med Chem; 2017 Dec; 141():721-733. PubMed ID: 29107429 [TBL] [Abstract][Full Text] [Related]
53. Activation of PI3K/Akt/mTOR signaling in the tumor stroma drives endocrine therapy-dependent breast tumor regression. Polo ML; Riggio M; May M; Rodríguez MJ; Perrone MC; Stallings-Mann M; Kaen D; Frost M; Goetz M; Boughey J; Lanari C; Radisky D; Novaro V Oncotarget; 2015 Sep; 6(26):22081-97. PubMed ID: 26098779 [TBL] [Abstract][Full Text] [Related]
54. AEG-1 is a target of perifosine and is over-expressed in gastric dysplasia and cancers. Huang W; Yang L; Liang S; Liu D; Chen X; Ma Z; Zhai S; Li P; Wang X Dig Dis Sci; 2013 Oct; 58(10):2873-80. PubMed ID: 23912246 [TBL] [Abstract][Full Text] [Related]
55. Defining biomarkers to predict sensitivity to PI3K/Akt/mTOR pathway inhibitors in breast cancer. Gonzalez-Angulo AM; Blumenschein GR Cancer Treat Rev; 2013 Jun; 39(4):313-20. PubMed ID: 23218708 [TBL] [Abstract][Full Text] [Related]
56. 4-Hydroxy estradiol but not 2-hydroxy estradiol induces expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor A through phosphatidylinositol 3-kinase/Akt/FRAP pathway in OVCAR-3 and A2780-CP70 human ovarian carcinoma cells. Gao N; Nester RA; Sarkar MA Toxicol Appl Pharmacol; 2004 Apr; 196(1):124-35. PubMed ID: 15050414 [TBL] [Abstract][Full Text] [Related]
57. In vitro and in vivo inhibition of neuroblastoma tumor cell growth by AKT inhibitor perifosine. Li Z; Tan F; Liewehr DJ; Steinberg SM; Thiele CJ J Natl Cancer Inst; 2010 Jun; 102(11):758-70. PubMed ID: 20463309 [TBL] [Abstract][Full Text] [Related]
58. Identification of magnetic resonance detectable metabolic changes associated with inhibition of phosphoinositide 3-kinase signaling in human breast cancer cells. Beloueche-Babari M; Jackson LE; Al-Saffar NM; Eccles SA; Raynaud FI; Workman P; Leach MO; Ronen SM Mol Cancer Ther; 2006 Jan; 5(1):187-96. PubMed ID: 16432178 [TBL] [Abstract][Full Text] [Related]
59. Perifosine induces differentiation and cell death in prostate cancer cells. Floryk D; Thompson TC Cancer Lett; 2008 Aug; 266(2):216-26. PubMed ID: 18395973 [TBL] [Abstract][Full Text] [Related]
60. Perifosine inhibits multiple signaling pathways in glial progenitors and cooperates with temozolomide to arrest cell proliferation in gliomas in vivo. Momota H; Nerio E; Holland EC Cancer Res; 2005 Aug; 65(16):7429-35. PubMed ID: 16103096 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]